SciClone and Joinn Laboratories set to joining frenzy for biotech IPOs in Hong Kong as fundraising jumps to highest in two years

Hong Kong has seen the most number of health care and pharmaceutical companies raising funds via initial public offering (IPO) in the first two months of 2021, the most since listing rules were …
( read original story …)